Brief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
07/10/2026 07:50
BRIEF-ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership Oct 7 (Reuters) - Abionyx Pharma SA ABNX.PA:
ABIONYX PHARMA AND OLON ENTER INTO STRATEGIC MANUFACTURING PARTNERSHIP TO PREPARE CER-001 BIOLOGIC FOR REGULATORY APPROVAL AND COMMERCIAL SUPPLY
ABIONYX PHARMA - MANUFACTURING ACTIVITIES TO BE CARRIED OUT AT TWO OLON SITES IN FRANCE
Source text: ID:nBw4dBDjSa
Further company coverage: ABNX.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls